
Opportune Therapeutics helps researchers understand how cannabis compounds affect health outcomes. It does this with drug discovery, drug design, and biosimulation powered by AI and machine learning. The company positions itself as a B2B offering, working with biotech and pharmaceutical partners as a data and analytics platform. Core tech includes AI/ML-enabled simulations, biosimulation workflows, and scalable analytics for cannabis-derived therapeutics. The approach targets faster, cost-efficient exploration of cannabinoid interactions to scale cannabis-based therapies.

Opportune Therapeutics helps researchers understand how cannabis compounds affect health outcomes. It does this with drug discovery, drug design, and biosimulation powered by AI and machine learning. The company positions itself as a B2B offering, working with biotech and pharmaceutical partners as a data and analytics platform. Core tech includes AI/ML-enabled simulations, biosimulation workflows, and scalable analytics for cannabis-derived therapeutics. The approach targets faster, cost-efficient exploration of cannabinoid interactions to scale cannabis-based therapies.